The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
Global Hyperbaric Oxygen Therapy market size is expected to reach $7.89 billion by 2030 at 9.7%, segmented as by monoplace hyperbaric oxygen therapy, single-chamber monoplace hbot systems, portable monoplace hbot systems
Read More
The hydronephrosis market is projected to reach $5.48 billion by 2030, growing at 10.1% CAGR, driven by aging populations, advanced diagnostics, and minimally invasive urology treatments.
Read More
Global Hydrocortisone market size is expected to reach $2.15 billion by 2030 at 5.7%, segmented as by cream, topical hydrocortisone cream (0.5%, 1%, 2.5%), hydrocortisone ointment
Read More
Global Hyaluronic Acid-based Dermal Fillers market size is expected to reach $9.09 billion by 2030 at 10.7%, the surge in demand for non-invasive dermatology drives hyaluronic acid-based dermal fillers market
Read More
Global Hutchinson-Gilford Progeria Syndrome (HGPS) market size is expected to reach $160 billion by 2030 at 8.5%, the increase in funding for research and development drives market growth
Read More
Global Huntington’s Disease market size is expected to reach $1.22 Billion by 2030 at 17.5%, rising neurological disorders fueling the growth of the market due to increasing diagnosis and aging population
Read More
Global Humira Biosimilar market size is expected to reach $6.53 by 2030 at 12.2%, the increasing prevalence of autoimmune diseases is fueling the growth of the market due to rising demand for tnf-blocking therapies
Read More
The Humanized Antibody market size is expected to reach $72.47 billion in 2030 at 12.7%, driven by rising incidence of cancer.
Read More
Global Human Respiratory Syncytial Virus Treatment market size is expected to reach $2.76 billion by 2030 at 8.5%, expansion of telehealth solutions fueling the growth of the market due to increasing adoption of digital healthcare technologies
Read More
Global Human Primary Cell Culture market size is expected to reach $6.39 billion by 2030 at 11%, growing emphasis on cell and gene therapies driving the market due to increasing demand for personalized regenerative treatments
Read More